dr. o'shaughnessy discusses negative tnbc iniparib trial results
Published 13 years ago • 482 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
1:28
dr. o'shaughnessy on precision medicine in triple negative breast cancer
-
2:04
dr. joyce o’shaughnessy on promising agents in triple-negative breast cancer
-
1:17
dr. o'shaughnessy on role of chemotherapy in future tnbc treatment
-
1:22
dr. o'shaughnessy on the utility of capivasertib in targeting akt in breast cancer
-
1:03
dr. o'shaughnessy on the future of tnbc treatment
-
1:02
dr. twelves on the value of the negative iniparib trial results
-
2:09
dr. o'shaughnessy on using phosphoprotein assays to personalize treatment for breast cancer
-
1:15
dr. tripathy discusses iniparib trial heterogeneity
-
1:07
dr. o'shaughnessy on avastin as her standard of care
-
1:51
dr. o'shaughnessy on breast cancer subtype-specific cytotoxic agents
-
7:06
tnt study in triple negative breast cancer
-
1:47
dr. joyce o'shaughnessy on treatment with everolimus in advanced breast cancer
-
1:40
dr. o'shaughnessy on the future of breast cancer biomarkers
-
1:41
dr. twelves describes iniparib clinical trials
-
1:20
dr. o’shaughnessy on eribulin as first-line therapy for metastatic her2-negative breast cancer
-
41:55
headline news in breast cancer with dr. joyce o'shaughnessy
-
4:07
px triplenegbreast seg01
-
26:31
targeting advanced triple-negative breast cancer | dana-farber cancer institute
-
8:32
immunotherapy for triple-negative breast cancer